Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03083184
PHASE3

Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients

Sponsor: University Hospital, Clermont-Ferrand

View on ClinicalTrials.gov

Summary

The purpose of this study is to assessed the efficacy of a combined solution of ethanol (4%) and low molecular weight heparins LMWH in preventing tunnelled dialysis catheter infection in chronic hemodialysis patients

Official title: Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients: a mulTi-centre, Randomized, Single Blind, Parallel Group studY (ETERNITY)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

400

Start Date

2018-02-09

Completion Date

2027-12

Last Updated

2023-12-08

Healthy Volunteers

No

Interventions

DRUG

Ethanol

An ethanol 40 % v/v - enoxaparin 1000 U/mL (Ethenox) interdialytic lock solution

DRUG

enoxaparin

An ethanol 40 % v/v - enoxaparin 1000 U/mL (Ethenox) interdialytic lock solution

Locations (1)

CHU Clermont-Ferrand

Clermont-Ferrand, France